Home > Insider Trading > Filing (0001209191-11-051455)

Filing Details

Accession Number:: 0001209191-11-051455
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-10-11 17:10:05
Reporting Period:: 2011-10-06

Filing Date:: 2011-10-11
Accepted Time:: 2011-10-11 17:10:05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1138400	Biomimetic Therapeutics Inc.	BMTI	Surgical & Medical Instruments & Apparatus (3841)	621786244

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1362155	Martin Earl Douglas	Biomimetic Therapeutics, Inc. 389 Nichol Mill Lane Franklin TN 37067	General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2011-10-06	3,000	$2.99	75,144	No	4	S	Direct
Common Stock	Disposition	2011-10-07	3,000	$3.02	72,144	No	4	S	Direct
Common Stock	Disposition	2011-10-10	3,000	$2.97	69,144	No	4	S	Direct
Common Stock	Disposition	2011-10-11	3,000	$3.01	66,144	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

This transaction represents the sale of 3,000 shares of common stock beneficially owned by the Reporting Person, and was made pursuant to the Reporting Person's participation in a Sales Plan to sell shares of the Issuer's common stock in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The Sales Plan was adopted in May 2011 and was designed to allow the Reporting Person to meet Federal income tax obligations due on October 15, 2011 resulting from alternative minimum tax liability based on the Reporting Person's exercise of Issuer's stock options in 2010.
This price represents the weighted average sales price of multiple transactions on the reported date at prices that ranged between $2.98 and $2.9907. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.
This price represents the weighted average sales price of multiple transactions on the reported date at prices that ranged between $3.0105 and $3.0205. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.
This price represents the weighted average sales price of multiple transactions on the reported date at prices that ranged between $2.95 and $2.9902. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.
This price represents the weighted average sales price of multiple transactions on the reported date at prices that ranged between $2.97 and $3.0202. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.